current news and archived releases from the Jefferson Health System are available.)
Adam P. Dicker, MD, PhD, New RTOG Vice-Chair for Translational Research
Adam P. Dicker, MD, PhD, has been appointed the Radiation Therapy Oncology Group (RTOG) Vice-Chair for Translational Research and chair of the RTOG translational research program (TRP) committee. Dr. Dicker is Associate Professor of Radiation Oncology and Director of the Division of Experimental Radiation Oncology in the Department of Radiation Oncology at Thomas Jefferson University in Philadelphia. RTOG is a clinical research enterprise component of the American College of Radiology (ACR).
“Dr. Dicker is an internationally respected researcher in the areas of the epidermal growth factor receptors (EGFR), nanoparticles, and brachytherapy for prostate cancer,” said Walter J. Curran, Jr., M.D., RTOG Group Chair and Clinical Director of the Kimmel Cancer Center at Thomas Jefferson University. “He has been an instrumental member of the RTOG TRP committee and I know that under his leadership the committee will continue to enhance the RTOG’s research efforts.” Dr. Dicker replaces Paul Okunieff, MD, of the University of Rochester who served in this position since 1999.
According to Dr. Dicker, “The RTOG translational research program is charged with translating basic research findings into clinical research questions. Our goal is to bring the promising developments found in the laboratory into clinical research as quickly as possible. RTOG, with its network of members in the United States, Canada and internationally, is in a unique position to identify and test this research.”
The RTOG TRP Committee sponsors research and educational programs that highlight emerging findings about tumor behavior, molecular mechanisms and the recent links between therapy and disease. TRP Committee members work with clinical scientists from both the academic and industrial communities to integrate new information into clinical trial designs. The TRP committee contributes directly to the research of the RTOG by conducting correlative studies, participating in the design of clinical studies, and evaluating protocol results to enhance and expand the hypotheses being tested.
The Radiation Therapy Oncology Group (RTOG) is a clinical research enterprise of the American College of Radiology (ACR), located in the ACR Philadelphia, PA office. RTOG is a multi-institutional international clinical cooperative group funded primarily by the National Cancer Institute. RTOG has over 30 years of experience in conducting clinical trials and is comprised of over 250 major research institutions in the United States and Canada. The group currently is conducting more than 40 active studies that involve radiation therapy alone or in conjunction with surgery and/or chemotherapeutic drugs or which investigate quality of life issues and their effects on the cancer patient.
The American College of Radiology (ACR) is a national professional organization serving more than 32,000 radiologists, radiation oncologists, interventional radiologists and medical physicists with programs focusing on the practice of radiology and the delivery of comprehensive health care services.